A leading medical technology company headquartered in the US, trusts in ClinFlows’ decidemedical solution for its upcoming EU Trial. Via the web-based platform, the complete patient screening process of the study including the subsequent 5-year follow-up phase will be organized and conducted: All medical images (DICOM) and documents will be handed in, reviewed, and evaluated in a GDPR-compliant manner via ClinFlows’ online service.
“We are excited to see this complex exchange of medical images and study documents, within such groundbreaking clinical trial, realized on our decidemedical platform, involving multiple prominent researchers in the cardiovascular space”, says Uwe Gladbach, founder and CEO of ClinFlows.
The online submission and review of required data allows fast turn around times between the study teams, when it comes to subject eligibility checks – also very beneficial for the patients to be treated in a timely manner.
ClinFlows’ decidemedical platform has registered users from 96 countries worldwide and is in use since more than 10 years.